Unknown

Dataset Information

0

Synthesis and Biological Evaluation of Umifenovir Analogues as Anti-SARS-CoV-2 Agents.


ABSTRACT: The unprecedented novel coronavirus disease 2019 (COVID-19) pandemic is a threat to global health and the economy. Since the outbreak of COVID-19, great effort has been made to reposition existing drugs to shorten development timelines, in addition to vaccine development and drug discovery campaigns. Umifenovir is a broad-spectrum antiviral agent used to treat influenza in China and Russia and is currently undergoing clinical trials for the treatment of COVID-19. In this article, the synthesis of umifenovir analogues and their biological evaluation are reported. The inhibitory activities of analogues against the binding of the spike glycoprotein (S-protein) of the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to the ACE2 receptor, which is a possible mode of action for umifenovir to inhibit viral infection, were investigated.

SUBMITTER: Tanaka H 

PROVIDER: S-EPMC9538379 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and Biological Evaluation of Umifenovir Analogues as Anti-SARS-CoV-2 Agents.

Tanaka Hiroaki H   Miyagi Seiya S   Yoshida Yusuke Y   Lamb Justin Steven JS   Chick Christian Nanga CN   Luhata Lokadi Pierre LP   Shibata Mizuho M   Tanaka Eri E   Suzuki Yumiko Y   Usuki Toyonobu T  

ChemistrySelect 20220809 30


The unprecedented novel coronavirus disease 2019 (COVID-19) pandemic is a threat to global health and the economy. Since the outbreak of COVID-19, great effort has been made to reposition existing drugs to shorten development timelines, in addition to vaccine development and drug discovery campaigns. Umifenovir is a broad-spectrum antiviral agent used to treat influenza in China and Russia and is currently undergoing clinical trials for the treatment of COVID-19. In this article, the synthesis o  ...[more]

Similar Datasets

| S-EPMC3968794 | biostudies-literature
| S-EPMC2064036 | biostudies-literature
| S-EPMC6774960 | biostudies-literature
| S-EPMC2112940 | biostudies-other
| S-EPMC10619477 | biostudies-literature
| S-EPMC3804772 | biostudies-literature
| S-EPMC6437665 | biostudies-literature
| S-EPMC8933873 | biostudies-literature
| S-EPMC6256754 | biostudies-literature
| S-EPMC9029309 | biostudies-literature